CClinicalTrials.gg
CompletedNCT00352157Updated Jul 21, 2009

Effect of Revival Soy on Weight Loss and Skin, Hair, and Nails in Premenopausal Women

A Phase 4 interventional study of Revival Soy Dietary Supplement in Skin Aging and Weight Loss, sponsored by Physicians Pharmaceuticals, Inc.. Completed at 1 site in United States. Open to female participants aged 25 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2009-07-21.

Sponsored by Physicians Pharmaceuticals, Inc. · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
25 Years to 45 Years
Sex
Female
01

Study summary

The purpose of this study is to determine if dietary consumption of Revival Soy can improve the appearance of the skin, hair, and finger nails and support weight loss in overweight, premenopausal women.

Read the detailed description

The researchers hypothesize that supplementation of Revival® Soy products to overweight premenopausal women as part of a soy-based meal replacement diet plan will:

  • Improve the health and appearance of the skin by normalizing skin pigmentation and reducing wrinkles,
  • Improve the health and appearance of hair by enhancing sheen and ease of combing, and
  • Improve the health and appearance of nails by enhancing shine, flexibility, and strength.
  • Stimulate a loss in weight and a reduction in the Body Mass Index (BMI),

For this study, obese (BMI = 30-40 kg/m2) premenopausal women (25-45 years of age) with mild to moderate photoaging (n=40) will receive either a Revival® soy shake (20 grams soy protein with 160 mg total isoflavones; n=20) or a placebo shake (20 grams of milk protein with 0 mg isoflavones; n=20) daily for 6 months. The subjects will be asked to come into the office for a total of seven visits, at baseline and at monthly intervals for 6 months. At baseline, month 3, and month 6, the subjects will be asked to complete a questionnaire in order to provide self-reported improvements related to hair, skin, and nail health. Following completion of the questionnaire, the investigator and the dermatology clinic staff will examine the subjects to assess the health and appearance of their skin, hair, and nails at baseline, month 3, and month 6.

After acceptance into the study, a registered dietitian will instruct the study subjects in the use of a low-energy (1,200 - 1,500 kcal/day) diet that incorporates 2 soy-based daily meal replacements (shakes, \~500 kcal), a minimum of 5 daily servings of fruits and vegetables (\~300 kcal), and one entrée (\~400 - 500 kcal). Subjects will be required to keep a dietary food intake record of all food and supplement use during the trial. Anthropometric data (height, body weight, waist circumference and hip circumference) will be collected at baseline and at monthly intervals.

02

Conditions studied

  • Skin Aging
  • Weight Loss

Keywords

  • Soy
  • Dermatology
  • Skin
  • Hair
  • Finger Nails
  • Weight Loss
  • Body Mass Index
  • Photoaging of Skin
  • Skin Wrinkling
03

In context

Body Weight

1,224 studies on the registry are indexed under Body Weight; 132 are open to participants now.

This study's enrollment of 40 is below the median of 64 across 948 interventional studies indexed under Body Weight.

Browse Body Weight studies →

Lead sponsor

This is the only study on the registry with Physicians Pharmaceuticals, Inc. as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Females
  • Age: 25-45 years.
  • BMI between 30 - 40 kg/m2.
  • Motivated to lose weight.
  • Subjects must be in general good health as determined from a medical history.
  • Subjects must have mild to moderate photoaging.
  • Subjects must use a shampoo from the approved list without change for the entire duration of the study.
  • Must not be consuming soy supplements or other soy products currently.
  • Must not be pregnant (negative pregnancy test at screening) and agree not to become pregnant during the course of the study.
  • Subjects must read and sign the informed consent form after the nature of the study has been fully explained.

Exclusion criteria

Exclusion Criteria:

  • Subjects with known allergies or sensitivities to ingredients contained in the dietary supplement.
  • Subjects who are required to spend excessive time in the sun (i.e. lifeguards, other outdoor workers).
  • Subjects who are currently participating or have participated within the last 4 weeks in any other clinical study (i.e., dermal patch, use tests, investigational drug or devices, etc.).
  • Subjects viewed by the investigator as not being able to complete the study.
  • Subjects who are unwilling to leave all of their current skin care products unchanged for the 6 months of the study.
  • Subjects who are unwilling to leave all of their current nail care products unchanged for the 6 months of the study.
  • Subjects who are unwilling to leave all of their current oral medications unchanged for the 6 months of the study.
  • Subjects who have experienced large variations in body weight during the previous 3 months
  • Subjects currently using other weight loss medications or supplements.
  • Subjects who had surgical intervention for the treatment of obesity.
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single
Enrollment
40 participants

Interventions

  • BehavioralRevival Soy Dietary Supplement
06

What researchers measure

Primary outcomes

  1. Investigator assessed appearance of skin (roughness, wrinkling, dyspigmentation, and redness) at baseline and after 3 and 6 months

  2. Investigator assessed appearance of hair (roughness, dullness, lack of manageability, and scalp flaking) at baseline and after 3 and 6 months

  3. Investigator assessed appearance of finger nails (roughness, ridging, flaking, and splitting) at baseline and after 3 and 6 months.

Secondary outcomes

  1. Body weight at monthly intervals

  2. Body mass index (BMI) at the baseline and study completion

  3. Subject-perceived changes in appearance of skin, hair, and finger nails at baseline and after 3 and 6 months

07

Study locations

1 site
  • Dermatology Consulting Services
    High Point, North Carolina 27262, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 21, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00352157
Lead sponsor
Physicians Pharmaceuticals, Inc.
Collaborators
Dermatology Consulting Services, High Point NC
First posted
Jul 14, 2006
Start date
Jul 2006
Completion
Mar 2007
Last update
Jul 21, 2009

Study contacts

Zoe D Draelos, M.D.
principal investigator · Dermatology Consulting Services, High Point NC
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion